Improved lifestyle is associated with improved depression, anxiety and well-being over time in UK healthcare professionals during the COVID-19 pandemic: insights from the CoPE-HCP cohort study.
COVID-19
Cohort Studies
Life Style
Longitudinal Studies
Mental Health
Journal
General psychiatry
ISSN: 2517-729X
Titre abrégé: Gen Psychiatr
Pays: England
ID NLM: 101735271
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
08
2022
accepted:
17
12
2022
entrez:
8
2
2023
pubmed:
9
2
2023
medline:
9
2
2023
Statut:
epublish
Résumé
One potential modifiable factor to improve the mental health of healthcare professionals (HCPs) during the pandemic is lifestyle. This study aimed to assess whether an improved lifestyle during the pandemic is associated with improved mental health symptoms and mental well-being in HCPs over time. This was a cohort study involving an online survey distributed at two separate time points during the pandemic (baseline (July-September 2020) and follow-up (December 2020-March 2021)) to HCPs working in primary or secondary care in the UK. Both surveys assessed for major depressive disorder (MDD) (Patient Health Questionnaire-9 (PHQ-9)), generalised anxiety disorder (GAD) (Generalised Anxiety Disorder-7 (GAD-7)), mental well-being (Short Warwick-Edinburgh Mental Well-being Score (SWEMWBS)) and self-reported lifestyle change (compared with the start of the pandemic) on multiple domains. Cumulative scores were calculated to estimate overall lifestyle change compared with that before the pandemic (at both baseline and follow-up). At each time point, separate logistic regression models were constructed to relate the lifestyle change score with the presence of MDD, GAD and low mental well-being. Linear regression models were also developed relating the change in lifestyle scores from baseline to follow-up to changes in PHQ-9, GAD-7 and SWEMWBS scores. 613 HCPs completed both baseline assessment and follow-up assessment. Consistent significant cross-sectional associations between increased lifestyle change scores and a reduced risk of MDD, GAD and low mental well-being were observed at both baseline and follow-up. Over the study period, a whole unit increase in the change in novel scores (ie, improved overall lifestyle) over 4 months was inversely associated with changes in PHQ-9 (adjusted coefficient: -0.51, 95% confidence interval (CI): -0.73 to -0.30, p<0.001) and GAD-7 scores (adjusted coefficient: -0.32, 95% CI: -0.53 to -0.10, p=0.004) and positively associated with the change in SWEMWBS scores (adjusted coefficient: 0.37, 95% CI: 0.18 to 0.55, p<0.001). Improved lifestyle over time is associated with improved mental health and mental well-being in HCPs during the pandemic. Improving lifestyle could be a recommended intervention for HCPs to help mitigate the mental health impact during the current and future pandemics. NCT04433260.
Sections du résumé
Background
UNASSIGNED
One potential modifiable factor to improve the mental health of healthcare professionals (HCPs) during the pandemic is lifestyle.
Aims
UNASSIGNED
This study aimed to assess whether an improved lifestyle during the pandemic is associated with improved mental health symptoms and mental well-being in HCPs over time.
Methods
UNASSIGNED
This was a cohort study involving an online survey distributed at two separate time points during the pandemic (baseline (July-September 2020) and follow-up (December 2020-March 2021)) to HCPs working in primary or secondary care in the UK. Both surveys assessed for major depressive disorder (MDD) (Patient Health Questionnaire-9 (PHQ-9)), generalised anxiety disorder (GAD) (Generalised Anxiety Disorder-7 (GAD-7)), mental well-being (Short Warwick-Edinburgh Mental Well-being Score (SWEMWBS)) and self-reported lifestyle change (compared with the start of the pandemic) on multiple domains. Cumulative scores were calculated to estimate overall lifestyle change compared with that before the pandemic (at both baseline and follow-up). At each time point, separate logistic regression models were constructed to relate the lifestyle change score with the presence of MDD, GAD and low mental well-being. Linear regression models were also developed relating the change in lifestyle scores from baseline to follow-up to changes in PHQ-9, GAD-7 and SWEMWBS scores.
Results
UNASSIGNED
613 HCPs completed both baseline assessment and follow-up assessment. Consistent significant cross-sectional associations between increased lifestyle change scores and a reduced risk of MDD, GAD and low mental well-being were observed at both baseline and follow-up. Over the study period, a whole unit increase in the change in novel scores (ie, improved overall lifestyle) over 4 months was inversely associated with changes in PHQ-9 (adjusted coefficient: -0.51, 95% confidence interval (CI): -0.73 to -0.30, p<0.001) and GAD-7 scores (adjusted coefficient: -0.32, 95% CI: -0.53 to -0.10, p=0.004) and positively associated with the change in SWEMWBS scores (adjusted coefficient: 0.37, 95% CI: 0.18 to 0.55, p<0.001).
Conclusions
UNASSIGNED
Improved lifestyle over time is associated with improved mental health and mental well-being in HCPs during the pandemic. Improving lifestyle could be a recommended intervention for HCPs to help mitigate the mental health impact during the current and future pandemics.
Trial registration number
UNASSIGNED
NCT04433260.
Identifiants
pubmed: 36751400
doi: 10.1136/gpsych-2022-100908
pii: gpsych-2022-100908
pmc: PMC9895916
doi:
Banques de données
ClinicalTrials.gov
['NCT04433260']
Types de publication
Journal Article
Langues
eng
Pagination
e100908Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Front Psychol. 2021 Feb 02;12:616280
pubmed: 33603701
BMJ Open. 2020 Dec 7;10(12):e041394
pubmed: 33293320
Asia Pac J Public Health. 2021 Nov;33(8):847-853
pubmed: 33829896
Obesity (Silver Spring). 2021 Feb;29(2):438-445
pubmed: 33043562
Nutrients. 2020 Oct 29;12(11):
pubmed: 33137947
Eur J Clin Nutr. 2020 Jun;74(6):852-855
pubmed: 32371988
Appetite. 2021 Mar 1;158:105019
pubmed: 33161046
Ann Intensive Care. 2021 Jul 10;11(1):106
pubmed: 34245380
Occup Med (Lond). 2021 Apr 9;71(2):62-67
pubmed: 33434920
J Sports Sci. 2021 Mar;39(6):699-704
pubmed: 33118469
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
J Med Internet Res. 2020 Oct 30;22(10):e22835
pubmed: 33038075
J Affect Disord. 2021 Dec 1;295:173-182
pubmed: 34469856
Can J Public Health. 2020 Dec;111(6):953-962
pubmed: 33170494
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Epidemiologia (Basel). 2021 Jun 22;2(3):227-242
pubmed: 36417222
Eur Addict Res. 2020;26(6):309-315
pubmed: 32961535
Am Psychol. 2011 Oct;66(7):579-92
pubmed: 21244124
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2021-2030
pubmed: 33099144
Appetite. 2021 Jan 1;156:104853
pubmed: 33038479
Neuropsychopharmacol Rep. 2022 Mar;42(1):109-113
pubmed: 35106943
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Occup Health. 2021 Jan;63(1):e12212
pubmed: 33683779
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jan-Mar;14(1):16-26
pubmed: 32962948
Int J Environ Res Public Health. 2021 Aug 10;18(16):
pubmed: 34444180